2024 Q2 Form 10-Q Financial Statement

#000092182524000044 Filed on April 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $164.1M $162.3M
YoY Change 7.83% 8.6%
Cost Of Revenue $43.05M $47.01M
YoY Change 8.29% 11.46%
Gross Profit $121.1M $115.3M
YoY Change 7.66% 7.48%
Gross Profit Margin 73.77% 71.03%
Selling, General & Admin $9.621M $11.78M
YoY Change 1.06% 25.95%
% of Gross Profit 7.95% 10.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $40.44M $33.96M
YoY Change 6.21% 7.3%
% of Gross Profit 33.39% 29.47%
Operating Expenses $52.67M $53.60M
YoY Change 5.11% 9.11%
Operating Profit $68.42M $61.66M
YoY Change 9.72% 6.1%
Interest Expense -$21.25M -$20.83M
YoY Change 13.53% -312.0%
% of Operating Profit -31.06% -33.79%
Other Income/Expense, Net -$15.90M $9.043M
YoY Change 176.57% -153.12%
Pretax Income $52.14M $70.28M
YoY Change -8.03% 74.35%
Income Tax $426.0K $1.179M
% Of Pretax Income 0.82% 1.68%
Net Earnings $51.32M $68.45M
YoY Change -5.98% 22.31%
Net Earnings / Revenue 31.27% 42.18%
Basic Earnings Per Share $0.39 $0.52
Diluted Earnings Per Share $0.39 $0.52
COMMON SHARES
Basic Shares Outstanding 132.3M shares 132.3M shares
Diluted Shares Outstanding 132.4M shares 132.4M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.55M $48.88M
YoY Change -43.4% -25.75%
Cash & Equivalents $38.55M $48.88M
Short-Term Investments
Other Short-Term Assets $224.6M $226.7M
YoY Change -0.16% -0.62%
Inventory $27.17M
Prepaid Expenses
Receivables $5.681M $12.46M
Other Receivables $151.7M $147.5M
Total Short-Term Assets $447.7M $435.5M
YoY Change 3.24% 0.92%
LONG-TERM ASSETS
Property, Plant & Equipment $4.702B $4.717B
YoY Change 1.8% 5.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $48.66M $47.74M
YoY Change 30.19% 40.63%
Other Assets $8.003M
YoY Change
Total Long-Term Assets $4.758B $4.765B
YoY Change 2.2% 5.43%
TOTAL ASSETS
Total Short-Term Assets $447.7M $435.5M
Total Long-Term Assets $4.758B $4.765B
Total Assets $5.206B $5.200B
YoY Change 2.29% 5.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $124.7M $116.2M
YoY Change -28.57% -33.33%
Accrued Expenses $17.84M $21.87M
YoY Change -19.64% -0.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $193.2M $188.7M
YoY Change -19.86% -21.46%
LONG-TERM LIABILITIES
Long-Term Debt $2.225B $2.232B
YoY Change 1.97% 7.26%
Other Long-Term Liabilities $108.3M $106.6M
YoY Change 3.95% 4.7%
Total Long-Term Liabilities $2.334B $2.338B
YoY Change 2.06% 7.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $193.2M $188.7M
Total Long-Term Liabilities $2.334B $2.338B
Total Liabilities $2.527B $2.527B
YoY Change -2.75% 4.3%
SHAREHOLDERS EQUITY
Retained Earnings $149.4M $147.1M
YoY Change 209.88% 308.77%
Common Stock $1.323M $1.323M
YoY Change 0.0% 0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.601B $2.595B
YoY Change
Total Liabilities & Shareholders Equity $5.206B $5.200B
YoY Change 2.29% 5.04%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $51.32M $68.45M
YoY Change -5.98% 22.31%
Depreciation, Depletion And Amortization $40.44M $33.96M
YoY Change 6.21% 7.3%
Cash From Operating Activities $107.7M $62.50M
YoY Change 25.58% -11.12%
INVESTING ACTIVITIES
Capital Expenditures $58.92M $68.38M
YoY Change -63.58% -31.55%
Acquisitions
YoY Change
Other Investing Activities $6.069M -$4.172M
YoY Change -59.02% -431.11%
Cash From Investing Activities -$52.85M -$19.03M
YoY Change -64.04% -81.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -57.22M -$38.43M
YoY Change -199.37% -2.98%
NET CHANGE
Cash From Operating Activities 107.7M $62.50M
Cash From Investing Activities -52.85M -$19.03M
Cash From Financing Activities -57.22M -$38.43M
Net Change In Cash -2.336M $5.040M
YoY Change -35.13% -106.86%
FREE CASH FLOW
Cash From Operating Activities $107.7M $62.50M
Capital Expenditures $58.92M $68.38M
Free Cash Flow $48.82M -$5.877M
YoY Change -164.24% -80.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24094000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24211000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48884000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43844000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132289039 shares
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
12463000 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
10993000 usd
CY2024Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
47735000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
44663000 usd
CY2024Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
147512000 usd
CY2023Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
144033000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
226656000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
203276000 usd
CY2024Q1 us-gaap Assets
Assets
5200381000 usd
CY2023Q4 us-gaap Assets
Assets
5175765000 usd
CY2024Q1 us-gaap Secured Debt
SecuredDebt
9896000 usd
CY2023Q4 us-gaap Secured Debt
SecuredDebt
9978000 usd
CY2024Q1 us-gaap Unsecured Debt
UnsecuredDebt
994644000 usd
CY2023Q4 us-gaap Unsecured Debt
UnsecuredDebt
994463000 usd
CY2024Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
921266000 usd
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
920863000 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
306000000 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
299000000 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
116161000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
143429000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
21865000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
21992000 usd
CY2024Q1 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
106586000 usd
CY2023Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
106734000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
50695000 usd
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
44201000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
2527113000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2540660000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
132341354 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132341354 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
132289039 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1323000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1323000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2414364000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2411673000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
147104000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
127707000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
32374000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22272000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2595165000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2562975000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
78103000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
72130000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2673268000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2635105000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5200381000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5175765000 usd
CY2024Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
159735000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
146606000 usd
CY2024Q1 fr Joint Venture Fees
JointVentureFees
669000 usd
CY2023Q1 fr Joint Venture Fees
JointVentureFees
1073000 usd
CY2024Q1 us-gaap Other Operating Income
OtherOperatingIncome
1868000 usd
CY2023Q1 us-gaap Other Operating Income
OtherOperatingIncome
1744000 usd
CY2024Q1 us-gaap Revenues
Revenues
162272000 usd
CY2023Q1 us-gaap Revenues
Revenues
149423000 usd
CY2024Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
47014000 usd
CY2023Q1 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
42182000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11781000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9354000 usd
CY2024Q1 fr Joint Venture Development Services Expense
JointVentureDevelopmentServicesExpense
426000 usd
CY2023Q1 fr Joint Venture Development Services Expense
JointVentureDevelopmentServicesExpense
784000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
41819000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39772000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
101040000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
92092000 usd
CY2024Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
30852000 usd
CY2023Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2024Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
20897000 usd
CY2023Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
16119000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
912000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
904000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9043000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-17023000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
70275000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
40308000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1402000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27634000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1179000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7167000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
70498000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
60775000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2046000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4808000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
68452000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
55967000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
45000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
47000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
68407000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
55920000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132360000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132211000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132406000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132299000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
70498000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
60775000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
10321000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-13020000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-102000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-102000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
80921000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
47857000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2323000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4482000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
78598000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43375000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2635105000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
10423000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7674000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.37
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
50309000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2024Q1 fr Retirement Of Limited Partner Units
RetirementOfLimitedPartnerUnits
-25000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
98000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2673268000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2530299000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12918000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4627000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.32
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
43460000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11358000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2527965000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
70498000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
60775000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
33962000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
31650000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
912000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
904000 usd
CY2024Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
12870000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7502000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1402000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27634000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
753000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5208000 usd
CY2024Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
30852000 usd
CY2023Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2024Q1 fr Straight Line Rent Adjustment Net
StraightLineRentAdjustmentNet
4165000 usd
CY2023Q1 fr Straight Line Rent Adjustment Net
StraightLineRentAdjustmentNet
5498000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
19374000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
12357000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-703000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
9768000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62499000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70318000 usd
CY2024Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
0 usd
CY2023Q1 us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
5559000 usd
CY2024Q1 us-gaap Payments For Leasing Costs Commissions And Tenant Improvements
PaymentsForLeasingCostsCommissionsAndTenantImprovements
68376000 usd
CY2023Q1 us-gaap Payments For Leasing Costs Commissions And Tenant Improvements
PaymentsForLeasingCostsCommissionsAndTenantImprovements
94336000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
47787000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Held For Sale
ProceedsFromSaleOfPropertyHeldForSale
0 usd
CY2024Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2614000 usd
CY2023Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2973000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4172000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1260000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19031000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104128000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2028000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2459000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
43220000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39713000 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
82000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
79000 usd
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
102000000 usd
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
80000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
95000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
66000000 usd
CY2024Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
98000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
11358000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38428000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-39609000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5040000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-73419000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43844000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145118000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48884000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71699000 usd
CY2024Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
2637000 usd
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
3981000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
868000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
861000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
200000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
56000 usd
CY2024Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
50695000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
44061000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2024Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 usd
CY2023Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
34731000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
60410000 usd
CY2024Q1 fr Tenant Improvements Funded By Tenant
TenantImprovementsFundedByTenant
0 usd
CY2023Q1 fr Tenant Improvements Funded By Tenant
TenantImprovementsFundedByTenant
2528000 usd
CY2024Q1 fr Write Off Of Fully Depreciated Assets
WriteOffOfFullyDepreciatedAssets
10940000 usd
CY2023Q1 fr Write Off Of Fully Depreciated Assets
WriteOffOfFullyDepreciatedAssets
10331000 usd
CY2024Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
421 property
CY2024Q1 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
19 state
CY2024Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
66700000 sqft
CY2024Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
421 property
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to conform with GAAP, in preparation of our Consolidated Financial Statements we are required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of March 31, 2024 and December 31, 2023, and the reported amounts of revenues and expenses for the three months ended March 31, 2024 and 2023. Actual results could differ from those estimates. In our opinion, the accompanying unaudited interim Consolidated Financial Statements reflect all adjustments necessary for a fair statement of our financial position as of March 31, 2024 and December 31, 2023, the results of our operations and comprehensive income for each of the three months ended March 31, 2024 and 2023, and our cash flows for each of the three months ended March 31, 2024 and 2023. All adjustments are of a normal recurring nature.</span></div>
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
252000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
606349000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
200364000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
556449000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
190453000 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
685600000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2239467000 usd
CY2024Q1 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
9514000 usd
CY2023Q4 us-gaap Loans Payable Fair Value Disclosure
LoansPayableFairValueDisclosure
9666000 usd
CY2024Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
894670000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
902042000 usd
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
925000000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
925000000 usd
CY2024Q1 us-gaap Lines Of Credit Fair Value Disclosure
LinesOfCreditFairValueDisclosure
306000000 usd
CY2023Q4 us-gaap Lines Of Credit Fair Value Disclosure
LinesOfCreditFairValueDisclosure
299000000 usd
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2135184000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
2135708000 usd
CY2024Q1 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
410000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
68407000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
55920000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132360000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132211000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
46000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
88000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132406000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132299000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
102704 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
130728 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9108000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6141000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1804000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1706000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
18234000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M20D
CY2024Q1 fr Receivable Due From Affiliates
ReceivableDueFromAffiliates
9270000 usd
CY2023Q4 fr Receivable Due From Affiliates
ReceivableDueFromAffiliates
9288000 usd
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000921825-24-000044-index-headers.html Edgar Link pending
0000921825-24-000044-index.html Edgar Link pending
0000921825-24-000044.txt Edgar Link pending
0000921825-24-000044-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fr-20240331.htm Edgar Link pending
fr-20240331.xsd Edgar Link pending
fr-20240331_g1.jpg Edgar Link pending
fr-2024331xex311.htm Edgar Link pending
fr-2024331xex312.htm Edgar Link pending
fr-2024331xex313.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fr-20240331_cal.xml Edgar Link unprocessable
fr-20240331_def.xml Edgar Link unprocessable
fr-20240331_lab.xml Edgar Link unprocessable
fr-20240331_pre.xml Edgar Link unprocessable
fr-20240331_htm.xml Edgar Link completed
fr-2024331xex314.htm Edgar Link pending
fr-2024331xex321.htm Edgar Link pending
fr-2024331xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending